Skip to main content
COVID-19 – high risk shielded patient list identification methodology

Amendment history

Summary

This summarises changes to this publication

Version Date Amendment history
0.1 23/03/2020 1st draft by head of secondary care analytics
0.2 23/03/2020 Inclusion of medication methodology by Prescribing, Medicines and Pharmacy Clinical lead
0.3 23/03/2020 Review and amendments by Head of Data management
0.4 23/03/2020 Review and amendments by Caldicott Guardian
0.5 24/03/2020 Update by Head of Data management
0.6 24/03/2020 Joint review by Head of Data management & Caldicott Guardian
0.7 24/03/2020 Draft Proofing by Head of Analytics Primary Care & Head of Communications 
0.8 24/03/2020 Final review by Head of Data management & Caldicott Guardian
0.9 24/03/2020 Sign off by Chief Medical Officer & Caldicott Guardian
1.0 24/03/2020 First version of Supporting Information
2.0 06/04/2020 Second version of supporting information
2.1 15/04/2020 Inclusion of processing steps using GP weekly COVID-19 dataset
2.2 15/04/2020 Review and amendments by Head of Data management
2.3 16/04/2020 Review and amendments by Caldicott Guardian
3.0 16/04/2020 Third version of Supporting Information
3.1 17/04/2020 Code movement between CMO categories, plus inclusion of additions and subtractions logic
3.2 17/04/2020 Review by Caldicott Guardian
4.0 17/05/2020 Fourth version of Supporting Information
4.1 05/05/2020 Review and amendment to date ranges by Head of Data management
4.2 05/05/2020 Review by Caldicott Guardian
6.0 07/05/2020 Sixth version of Supporting Information
8.0 22/05/2020 Eighth version of Supporting Information
9.0 1/08/2020 Detained Person's SPL introduced
Last edited: 3 August 2020 8:47 am

Publication chapters

  1. COVID-19 – high risk shielded patient list identification methodology
  2. Background
  3. Dataset usage
  4. Rule logic
  5. Medicines data
  1. Assurance
  2. Additions and subtractions
  3. Annexes
  4. Amendments from previous version

  5. Amendment history